Mannkind Corp

NASDAQ: MNKD
$7.44
+$0.18 (+2.5%)
Closing Price on November 6, 2024

MNKD Articles

The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
Judging by the most shorted stocks traded on the Nasdaq late last month, short sellers took a wait and see approach to the Trump rally.
The November 15 short interest data have been compared with the previous report, and short interest increased in most of the selected biotech stocks.
Here are the top 10 most shorted stocks traded on the Nasdaq, as of the November 15 settlement date.
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for just now at...
Shorts sellers seemed to grow wary as October wound down and the holiday shopping season and presidential election approached, at least judging by the most shorted stocks traded on the Nasdaq.
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Frontier Communications remained the most shorted stock traded on the Nasdaq between the September 30 and October 14 settlement dates.
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
Short sellers retreated from Sirius XM just enough between the September 15 and September 30 settlement dates for it to slip out of the top spot on the list of the most shorted stocks traded on the...
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
The return of volatility to the markets after the doldrums of August appears to have pointed short sellers at rival chipmakers Intel and AMD.
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
The short interest moves in the most shorted stocks traded on the Nasdaq were mixed between the August 15 and August 31 settlement dates. But short sellers clearly had a couple of favorites.
At this point, bad news is coming in consistently to the point that any significant piece of good news could catapult Sanofi stock higher, making it an interesting choice for dip-buyers.